Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-90.12	-8.42	85.26
Graham Fair Price	450.68	19.93	3.62
PEG	-99.88	< 0.005	0.35
Price/Book	21.97	0.70	0.57
Price/Cash Flow	-87.64	60.38	488.32
Prices/Earnings	-96.16	-1.40	36.42
Price/Sales	61.77	17.66	10.92
Price/FCF	-87.64	60.38	488.32
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	29.02	0.51	0.40
Operating Margin	1103.25	-4.11	0.34
ROA	3378.47	-0.04	< 0.005
ROE	< 0.005	-0.13	3075.42
ROIC	< 0.005	-0.08	1943.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.34	< 0.005	-12055.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.14	-9.87	767.41
EPS QOQ	1.04	-32.11	2977.83
FCF QOQ	-0.94	8.64	823.19
Revenue QOQ	-0.77	-0.26	65.82
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	46.60	78.13	67.66
Days Sales Outstanding (DSO)	2526.30	2724.94	7.86
Inventory Turnover	1.93	1.15	-40.35
Debt/Capitalization	0.53	0.44	-18.09
Quick Ratio	1.20	-0.04	-96.98
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	12.15	11.87	-2.28
Cash	0.96	-14.55	1417.80
Capex	< 0.005	< 0.005	41.32
Free Cash Flow	0.01	0.14	864.00
Revenue	0.64	0.47	-26.32
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.26	2.19	73.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	55.35	-4.13	-92.53
Naive Interpretation	Member

06 - Financial Health · Bad

Rating